# Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting

> **NCT00395785** · PHASE2,PHASE3 · TERMINATED · sponsor: **Kensey Nash Corporation** · enrollment: 400 (estimated)

## Conditions studied

- Carotid Stenosis

## Interventions

- **DEVICE:** Carotid Stent Implantation
- **DEVICE:** Embolic Protection

## Key facts

- **NCT ID:** NCT00395785
- **Lead sponsor:** Kensey Nash Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 400 (ESTIMATED)
- **Why stopped:** Sponsor elected to not pursue this indication for the study device.
- **Last updated:** 2007-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395785, "Evaluation of the TriActiv ProGuard System During Carotid Artery Stenting". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00395785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*